EducationDynamics (EDDY), the nation’s leading expert in reputation management and revenue growth for higher education institutions, unveiled its newly retooled report Engaging the Modern Learner: ...
Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback